Quarterly report pursuant to Section 13 or 15(d)

Research and Development Costs (Tables)

v3.23.2
Research and Development Costs (Tables)
6 Months Ended
Jun. 30, 2023
Research and Development [Abstract]  
Schedule of Research and Development Costs

A summary of research and development costs for the three months and six months ended June 30, 2023 and 2022, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs have been incurred.

 

    2023     2022     2023     2022  
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2023     2022     2023     2022  
                         
United States   $ 87,625     $ 80,290     $ 223,531     $ 154,821  
Spain     272,564       18,774       273,539       347,604  
China     14,090       16,860       14,090       17,720  
Netherlands     53,178       48,886       105,382       103,116  
Total   $ 427,457     $ 164,810     $ 616,542     $ 623,261